Biostate AI

Website

Biostate AI, Inc

7 Investors
Biotechnology and Health Tech
Houston, TX

Biostate AI, Inc. is a biotech company focused on transforming the analysis of biological data through the use of generative artificial intelligence. Founded in 2023, the company aims to enhance the efficiency and accuracy of health research, particularly in the life sciences and biotechnology sectors.

Products & Team

AI-Powered RNASeq Analysis Platform

Biological Data AnalysisSeed

Biostate AI’s core platform offers comprehensive analysis of biological samples, focusing primarily on total RNA sequencing. This end-to-end solution transforms raw samples into actionable insights using advanced generative AI algorithms, helping researchers interpret complex datasets effectively.

Value Proposition

The platform solves the problem of inconsistent and slow data analysis in biological research, providing researchers with rapid, reliable results that enhance decision-making in projects ranging from drug discovery to precision medicine.

Pain Points

Researchers face challenges in obtaining consistent and actionable insights from complex biological data, often requiring significant time and expertise for analysis.

End-to-end RNASeq analysisGenerative AI algorithms for data interpretationStreamlined workflows from sample to insightHigh-throughput analysis capabilities
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
Houston, TX
Primary headquarters

Funding History

Total Raised:
$4.2M
E

Equity, Security Offering

April 2025
$13.0M
Target
Progress
32%
Raised
$4.2M
Target
$13.0M
#000199076225000001